Editors/Authors
Librarians
Newsletter
Site Tour
Subscriptions
A-Z Index
About
Contact Us
Help
Log In
|
Log In via Athens
select
All JAMAevidence
Users' Guides (UG)
Rational Clinical Exam (RCE)
Care at the Close of Life (CCL)
UG Education Guides
RCE Education Guides
CCL Education Guides
Glossary
Images
Disable Autosuggest
<
Back
aspirin
All results
|
Images only
Users' Guides to the Medical Literature
1-12 of 12
results
1.
Part B Therapy >
Chapter 6. Therapy (Randomized Trials)
>
Clinical Resolution
2.
Part G Moving from Evidence to Action >
Chapter 21. How to Use a Patient Management Recommendation
>
Clinical Resolution
3.
Part B Therapy >
Chapter 6. Therapy (Randomized Trials)
>
Clinical Scenario
4.
Part B Therapy >
Chapter 8. Confidence Intervals
>
Interpreting Apparently "Positive" Trials
5.
Part B Therapy >
Chapter 6. Therapy (Randomized Trials)
> Are the Results Valid? >
Using the Guide—Part 1
6.
Part B Therapy >
Chapter 11.2. Example Numbers Needed to Treat
> The Number Needed to Treat in Weighing Benefit and Harm—Other Examples >
As a result of taking aspirin, patients with hypertension without known coronary artery disease...
7.
Part B Therapy >
Chapter 11.1. Applying Results to Individual Patients
> Introduction > Have Biologic Factors That Might Modify the Treatment Response Been Excluded? > Sex >
Figure 11.1-1. Meta-analysis of Aspirin in the Primary Prevention of Myocardial Infarction and...
View large
|
View in context
8.
Part G Moving from Evidence to Action >
Chapter 22.4. Grading Recommendations
> Strength of the Recommendation > Interpreting Strong and Weak Recommendations >
For instance, consistent results from high-quality randomized trials suggest that aspirin (...
9.
Part B Therapy >
Chapter 10.4. Composite Endpoints
> Can One Be Confident That the Component Endpoints Share Similar Relative Risk Reductions? > Is the Underlying Biology of the Component Endpoints Similar Enough That One Would Expect Similar Relative Risk Reductions? >
In contrast, the authors of the Clopidogrel Versus Aspirin in Patients at Risk of Ischaemic...
10.
Part G Moving from Evidence to Action >
Chapter 21. How to Use a Patient Management Recommendation
> Developing Recommendations >
In patients such as the woman with nonvalvular atrial fibrillation described in the opening...
11.
Part B Therapy >
Chapter 10.4. Composite Endpoints
> Are the Component Endpoints of the Composite Endpoint of Similar Importance to Patients? >
On the other hand, consider a trial of 4 doses of perioperative aspirin in patients undergoing...
12.
Part B Therapy >
Chapter 9.2. Surprising Results of Randomized Trials
> When Randomized Controlled Trial Results Have Contradicted Observational Studies of Patient-Important Endpoints >
Table 9.2-3 Refuted Evidence From Observational Studies
a
RELATED SEARCH
JAMA
JAMA
and
Archives
journals
PubMed
Google Scholar
Not finding what you are looking for?
Do a full-text search for '
aspirin
'.
Copyright © American Medical Association. All rights reserved. | JAMA | McGraw-Hill Global Education Holdings, LLC.
Privacy Notice
. Any use is subject to the
Terms of Use
and
Notice
.
Additional Credits and Copyright Information
.
Your IP address is 50.19.155.235